A new generation of AI systems does not just assist scientists; it organizes itself into research teams, designs experiments, debates hypotheses, and identifies drug candidates at speeds no human laboratory…
🔬 Aging Redefined as Systems Failure: Researchers in Berlin are shifting the aging conversation toward preserving biological coordination across systems, not fixing a single defect. 🤖 AI Drug Discovery Reaches Scale: Over 173 AI-discovered drug programs are now in clinical trials, and a new free platform targeting global diseases launched this week. 😴 Sleep as a Disease Predictor: Stanford's SleepFM AI model predicts 130+ conditions from one night of sleep data, positioning sleep as a critical longevity biomarker. 🦠 Gut Microbiome Controls Immunity Directly: Common gut microbes inject proteins into immune cells, and a single bacterial metabolite doubled lung cancer immunotherapy response in mice. ❤️ Long-Term Heart-Aging Study Begins: UTMB's decade-long Galveston Heart Study will track thousands of participants to uncover how cardiovascular and brain health intersect with aging.
New research from three landmark 2026 studies reveals that continuous glucose monitors can detect hidden metabolic dysfunction, predict cardiovascular risk, and personalize nutrition in people without diabetes. The science is…
A foundation model company just paid $400 million in stock for a team of fewer than 10 people. The implications for drug discovery, precision medicine, and the entire healthcare AI…
A convergence of cfDNA methylation analysis, multi-omics integration, and artificial intelligence is transforming cancer screening. From the PATHFINDER 2 trial showing a seven-fold increase in cancer detection to the PROMISE…
A landmark Cell Reports Medicine study analyzed the genome, epigenome, microbiome, and metabolome of Maria Branyas Morera, the world’s oldest verified person. The findings reveal that extreme longevity results from…
🔬 Epigenetic Reprogramming Enters Human Trials — The FDA cleared the first partial de-aging trial using OSK reprogramming factors, targeting vision restoration in glaucoma patients. 🧠 Diet and APOE Genetics Collide — Higher meat intake correlated with slower cognitive decline in older adults carrying Alzheimer's risk genes, upending common dietary assumptions. 🤖 NVIDIA and Lilly Bet $1 Billion on AI Drug Discovery — A landmark co-innovation lab in San Francisco will embed AI engineers alongside biologists to redesign how medicines are discovered. 🦠 Gut Bacteria Act Like Syringes — Common gut microbes can inject proteins directly into human cells, reshaping how researchers understand microbiome-immune crosstalk. 😴 Circadian Fragmentation Doubles Dementia Risk — Weak internal body clocks are now confirmed as a significant, and potentially modifiable, risk factor for dementia.
ARPA-H’s $144 million PROSPR program is testing rapamycin, semaglutide, and dapagliflozin in 726 healthy older adults, funding a first-in-humans trial of a retrotransposon-silencing HIV drug, and building a validated biological…
🧬 Cellular Reprogramming Enters Human Trials — Life Biosciences has launched the first FDA-approved partial de-aging trial, translating Sinclair's epigenetic reprogramming research from animal models to human medicine. 🧠 Gut-Brain Axis Reverses Memory Loss — Stanford's Nature study shows that correcting age-related gut bacteria shifts restores youthful cognitive performance by reactivating vagus nerve signaling to the hippocampus. 🤖 AI Drug Discovery Reaches Clinical Scale — 173+ AI-designed drug candidates are now in clinical trials, and longevity medicine is being advised to prepare for AI therapeutics to arrive in clinical practice imminently. 🦠 Gut Microbiome as Active Immune Regulator — New research reveals gut bacteria actively inject proteins into cells to modulate immunity, and a microbiome-derived molecule doubled lung cancer immunotherapy response rates in mice. 😴 Circadian Fragmentation Doubles Dementia Risk — A large Neurology journal study found that weak or late-peaking daily activity rhythms more than double the risk of dementia, making circadian optimization a key prevention target.
A growing body of clinical evidence shows that resistance training reduces depression symptoms as effectively as frontline medications, slows cognitive decline in aging adults, and triggers neurobiological changes that no…
Zach RobertsSign up for personalized wellness coaching and the Daily Discovery Newsletter.